581 Search Results


compound  (Aptose Biosciences)
86
Aptose Biosciences compound
Compound, supplied by Aptose Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/sec_filing____882361_slash_000117184319002540_slash_exh_1015-67-43-18?v=Aptose+Biosciences
Average 86 stars, based on 1 article reviews
compound - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
hy-d1301  (medchemexpress)
97
medchemexpress hy-d1301
Hy D1301, supplied by medchemexpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/pmc12704262-71-0-4?v=medchemexpress
Average 97 stars, based on 1 article reviews
hy-d1301 - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier
granzyme b fitc rea226 miltenyi  (Miltenyi Biotec)
95
Miltenyi Biotec granzyme b fitc rea226 miltenyi
Granzyme B Fitc Rea226 Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/pmc07455120__jciinsight___5___138729___s089-0-31-35?v=Miltenyi+Biotec
Average 95 stars, based on 1 article reviews
granzyme b fitc rea226 miltenyi - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
anti il10 apc antibodies  (Miltenyi Biotec)
93
Miltenyi Biotec anti il10 apc antibodies
Anti Il10 Apc Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/pmc04504352-44-8-11?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
anti il10 apc antibodies - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
anti human vδ1  (Miltenyi Biotec)
94
Miltenyi Biotec anti human vδ1
Frequency of <t>Vδ1+</t> and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Anti Human Vδ1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/pmc09656060-47-31-39?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
anti human vδ1 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
serca2  (Novus Biologicals)
94
Novus Biologicals serca2
Frequency of <t>Vδ1+</t> and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Serca2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/pm39499286-378-10-12?v=Novus+Biologicals
Average 94 stars, based on 1 article reviews
serca2 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
hct 116  (DSMZ)
96
DSMZ hct 116
Frequency of <t>Vδ1+</t> and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Hct 116, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/bio_rxiv__64898__2026__03__11__711115-176-60-90?v=DSMZ
Average 96 stars, based on 1 article reviews
hct 116 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
cd144 ve cadherin antibody  (Miltenyi Biotec)
94
Miltenyi Biotec cd144 ve cadherin antibody
Frequency of <t>Vδ1+</t> and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Cd144 Ve Cadherin Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/pm40848716-322-7-19?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
cd144 ve cadherin antibody - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
tryptamine  (BOC Sciences)
90
BOC Sciences tryptamine
Frequency of <t>Vδ1+</t> and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Tryptamine, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/pmc06500160-405-20-28?v=BOC+Sciences
Average 90 stars, based on 1 article reviews
tryptamine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
ketamine hydrochloride  (Toronto Research Chemicals)
93
Toronto Research Chemicals ketamine hydrochloride
Frequency of <t>Vδ1+</t> and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Ketamine Hydrochloride, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/10__1186_slash_s41935___018___0048___8-37-0-5?v=Toronto+Research+Chemicals
Average 93 stars, based on 1 article reviews
ketamine hydrochloride - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
serca atpase antibody  (Novus Biologicals)
93
Novus Biologicals serca atpase antibody
Frequency of <t>Vδ1+</t> and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Serca Atpase Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/pmc09054024-269-10-13?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
serca atpase antibody - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
sdz 220 581  (Tocris)
99
Tocris sdz 220 581
Frequency of <t>Vδ1+</t> and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Sdz 220 581, supplied by Tocris, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/581/pm17728388-55-28-30?v=Tocris
Average 99 stars, based on 1 article reviews
sdz 220 581 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


Frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.

Journal: Cells

Article Title: Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins

doi: 10.3390/cells11213449

Figure Lengend Snippet: Frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. ( A ) Distribution of percentages of total lymphocytes, T (CD3+), Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Shown is mean ± SD. ( B ) Representative dot-plots showing the frequency of Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.

Article Snippet: After the incubation, the cells were harvested, washed with FACS buffer and surface stained using the following fluorochrome-conjugated monoclonal antibodies: APC-Cy7-conjugated anti-human CD45 (clone REA747), PerCP-Vio700-conjugated anti-human CD3 (clone REA613), FITC-conjugated anti-human Vδ1 (clone REA173), or Vδ2 (clone REA771) (Miltenyi Biotec).

Techniques:

Phenotypic analysis of circulating Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. Distribution of ex vivo memory subsets of Vδ1+ ( A ) and Vδ2+ ( C ) T lymphocytes based on the expression of CD27 and CD45RA in hospitalized and recovered COVID-19 patients, compared to healthy donors. Median is shown. Healthy donors were represented as triangle, COVID-19 patients as circle and COVID-19 recovered as rhombus. Representative dot-plots showing Vδ1+ ( B ) and Vδ2+ ( D ) T lymphocyte memory subset distribution in hospitalized, recovered, and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.

Journal: Cells

Article Title: Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins

doi: 10.3390/cells11213449

Figure Lengend Snippet: Phenotypic analysis of circulating Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and in healthy subjects. Distribution of ex vivo memory subsets of Vδ1+ ( A ) and Vδ2+ ( C ) T lymphocytes based on the expression of CD27 and CD45RA in hospitalized and recovered COVID-19 patients, compared to healthy donors. Median is shown. Healthy donors were represented as triangle, COVID-19 patients as circle and COVID-19 recovered as rhombus. Representative dot-plots showing Vδ1+ ( B ) and Vδ2+ ( D ) T lymphocyte memory subset distribution in hospitalized, recovered, and healthy subjects. * p < 0.05, ** p < 0.01, **** p < 0.0001.

Article Snippet: After the incubation, the cells were harvested, washed with FACS buffer and surface stained using the following fluorochrome-conjugated monoclonal antibodies: APC-Cy7-conjugated anti-human CD45 (clone REA747), PerCP-Vio700-conjugated anti-human CD3 (clone REA613), FITC-conjugated anti-human Vδ1 (clone REA173), or Vδ2 (clone REA771) (Miltenyi Biotec).

Techniques: Ex Vivo, Expressing

Analysis of exhaustion-marker expression by circulating Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. Expression of TIM-3 and PD-1 on Vδ1+ ( A ) and Vδ2+ ( B ) T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy donors. Shown are percentage ( left panels ) and MFI ( right panels ) ± SD. ( C ) Representative dot-plots of exhaustion-marker expression by Vδ1+ and Vδ2+ T lymphocytes from hospitalized and recovered COVID-19 patients, compared to healthy donors. ( D ) Frequency of exhausted Vδ1+ and Vδ2+ T cells per 1 × 10 6 T lymphocytes. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Journal: Cells

Article Title: Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins

doi: 10.3390/cells11213449

Figure Lengend Snippet: Analysis of exhaustion-marker expression by circulating Vδ1+ and Vδ2+ T lymphocytes in hospitalized and recovered COVID-19 patients and healthy subjects. Expression of TIM-3 and PD-1 on Vδ1+ ( A ) and Vδ2+ ( B ) T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy donors. Shown are percentage ( left panels ) and MFI ( right panels ) ± SD. ( C ) Representative dot-plots of exhaustion-marker expression by Vδ1+ and Vδ2+ T lymphocytes from hospitalized and recovered COVID-19 patients, compared to healthy donors. ( D ) Frequency of exhausted Vδ1+ and Vδ2+ T cells per 1 × 10 6 T lymphocytes. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Article Snippet: After the incubation, the cells were harvested, washed with FACS buffer and surface stained using the following fluorochrome-conjugated monoclonal antibodies: APC-Cy7-conjugated anti-human CD45 (clone REA747), PerCP-Vio700-conjugated anti-human CD3 (clone REA613), FITC-conjugated anti-human Vδ1 (clone REA173), or Vδ2 (clone REA771) (Miltenyi Biotec).

Techniques: Marker, Expressing

Expression of pro-inflammatory cytokines by Vδ1+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Cumulative histograms representing the expression of pro-inflammatory cytokines by Vδ1+ T lymphocyte. Shown are percentage ( left panels ), MFI ( central panel , log 10 scale), and iMFI ( right panels ) ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Journal: Cells

Article Title: Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins

doi: 10.3390/cells11213449

Figure Lengend Snippet: Expression of pro-inflammatory cytokines by Vδ1+ T lymphocytes in hospitalized and recovered COVID-19 patients, compared to healthy subjects. Cumulative histograms representing the expression of pro-inflammatory cytokines by Vδ1+ T lymphocyte. Shown are percentage ( left panels ), MFI ( central panel , log 10 scale), and iMFI ( right panels ) ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Article Snippet: After the incubation, the cells were harvested, washed with FACS buffer and surface stained using the following fluorochrome-conjugated monoclonal antibodies: APC-Cy7-conjugated anti-human CD45 (clone REA747), PerCP-Vio700-conjugated anti-human CD3 (clone REA613), FITC-conjugated anti-human Vδ1 (clone REA173), or Vδ2 (clone REA771) (Miltenyi Biotec).

Techniques: Expressing